Skip to main content
. 2009 Jan 6;87(2):130–138. doi: 10.2471/BLT.08.050963

Table 3. Clinical and delivery variables for infants who died within 28 days postpartum and for those who survived in prospective study of neonatal mortality in an urban Pakistani population, 2003–2005.

Variables Death within 28 days (n = 53) Surviving infant
(n = 1066) RR (95% CI)
No. (%)a No. (%)a
Gestational age at birth (n = 1119)
< 37 weeks 31 (58.5) 189 (17.7) 5.8 (3.4–9.7)
≥ 37 weeks (reference) 22 (41.5) 877 (82.3) 1.0 (NA)
Birth weight (n = 1021)
< 2000 g 6 (26.1) 55 (5.5) 5.6 (2.3–13.6)
≥ 2000 g (reference) 17 (73.9) 943 (94.5) 1.0 (NA)
Gender (n = 1055)
Male 22 (46.8) 521 (51.7) 0.8 (0.5–1.5)
Female (reference) 25 (53.2) 487 (48.3) 1.0 (NA)
Place of delivery (n = 1121)
Home 10 (18.9) 218 (20.3) 0.9 (0.5–1.8)
Hospital or other health-care facility (reference) 43 (81.1) 850 (79.6) 1.0 (NA)
Birth attendant (n = 1111)
Traditional birth attendant or other 6 (11.5) 175 (16.5) 0.6 (0.3–1.4)
Nurse, midwife or equivalent 9 (17.3) 256 (24.2) 0.6 (0.3–1.2)
Doctor (reference) 37 (71.2) 628 (59.3) 1.0 (NA)
Mode of delivery (n = 1068)
Vaginal (reference) 30 (63.8) 830 (81.3) 1.0 (NA)
Caesarean section 17 (36.2) 191 (18.7) 2.3 (1.3–4.2)
Preterm rupture of membranes (n = 1116)
< 12 hours (reference) 46 (90.2) 1000 (93.9) 1.0 (NA)
12–24 hours 5 (9.8) 65 (6.1) 1.6 (0.7–4.0)
Colour of amniotic fluid (n = 995)
Clear (reference) 28 (63.6) 793 (83.4) 1.0 (NA)
Meconium-stained 12 (27.3) 116 (12.2) 2.7 (1.4–5.3)
Other 4 (9.1) 42 (4.4) 2.5 (0.9–7.0)
Amniotic fluid odour (n = 975)
Foul-smelling 9 (23.8) 76 (7.8) 3.1 (1.5–6.2)
Not foul-smelling (reference) 32 (76.2) 858 (92.2) 1.0 (NA)
Prolonged labour (n = 1066)
Yes 4 (8.5) 137 (13.4) 0.6 (0.2–1.7)
No (reference) 43 (91.5) 882 (86.6) 1.0 (NA)
Vaginal bleeding (n = 1019)
Excessive 6 (13.3) 59 (6.0) 2.3 (1.0–5.1)
Normal (reference) 39 (86.7) 915 (94.0) 1.0 (NA)
Antepartum fever with chills (n = 1056)
Yes 7 (15.6) 90 (8.9) 1.9 (0.9–4.1)
No (reference) 38 (84.4) 921 (91.0) 1.0 (NA)

CI, confidence interval; NA, not applicable; RR, relative risk.
a Denominators for demographic and clinical characteristics may differ due to non-response.